Controversias sobre el uso de bloqueadores neuromusculares en el síndrome de insuficiencia respiratoria aguda

Abstract

Neuromuscular blockers are drugs that are used as a complement to general anesthesia. To update review of the literature on the use of neuromuscular blockers in acute respiratory failure syndrome. The possibility of use in this context has opened a vast field of research. Its prolonged administration has been associated with complications and despite the controversies about its use, in recent years it has been observed that it can be considered an adjuvant drug for the treatment of this syndrome. It is necessary to increase the scientific evidence to guarantee a high safety profile of these drugs as adjuvants in the treatment of acute respiratory failure syndrome before their systematic use can be recommended. In light of current knowledge and the controversy of the subject, the indication of these drugs should be individualized in the critical patient in general and in that with acute respiratory distress syndrome in particular.